AI tools are pivotal in combating AI-driven cyberattacks, providing advanced systems that can adequately meet hacking challenges by tracking and counteracting threats, according to Mobihealth News.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
